.png)
About the Founder
Lauren S. Baker, PhD
Insight was founded in 2021 by Lauren S. Baker, PhD. Lauren has a unique background that has leveraged her technical engineering background and strong medical experience. She received a Bachelor’s Degree in Chemical Engineering and a Masters and PhD in Mechanical Engineering with an emphasis on cardiovascular fluid mechanics. Her engineering expertise was applied to the medical arena during her tenure at UMASS Medical School where she served as an assistant professor of cardiac surgery. She performed both clinical and preclinical research and taught both medical students/surgical residents as well as engineering students on the fundamentals of cardiac mechanics and the technical application of engineering principles to the cardiovascular system. She transitioned from academia to industry when she worked at Boston Scientific Corporation (BSC).
Her entrepreneurial spirit thrived at BSC during the time when the company expanded from a privately held “small” entity to a formidable public company. She worked with the engineering teams as well as clinical and regulatory to refine the necessary interaction of these critical pillars of successful product development. Her role was refined when she established the international clinical research presence for BSC and expanded to take on the role of Head of Corporate Clinical Research.
In 2000, Dr. Baker established Boston Biomedical Associates, a boutique consulting and clinical research organization that leveraged her experiences from BSC to support multiple companies in multiple therapeutic areas. She continued to grow the business organically and ultimately sold the business as part of a roll-up of several internationally-based small consulting and CRO entities to form what is today branded as Avania. She has now exited from Avania to establish Insight Medical Consulting where she and her team are assisting companies with regulatory and clinical strategy work. These consultancies include preparing for interactions with FDA, developing international strategies for submissions as well as clinical trial design strategies.